InspiroGene by McKesson Selected as the Specialty Pharmacy Partner for Iovance’s Amtagvi®—First Cell Therapy Approved for Solid Tumors
Biologics by McKesson, in partnership with InspiroGene, supports Amtagvi, the first FDA-approved one-time cell therapy for a solid tumor in patients with unresectable or metastatic melanoma.